EUVIMEDEUVIMED entdecken
Open Access

Erythrocyte patch for enhanced B cell depletion therapy

Jiaqi Liu iD, Fengju Wang iD, Lian Li iD

Science Advances · 22.05.2026 · 12 (21)

DOI: 10.1126/sciadv.aed3138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 22.05.2026. Verfasst von Jiaqi Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Lymphocyte Depletion, B-Lymphocytes, Erythrocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, National key R&D program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated B cells are central to many hematologic malignancies and autoimmune diseases, but current B cell–targeted therapies often fail to translate binding into effective signaling. Here, we present CD20 EryPatch, a living dynamic cellular patch that co-opts natural erythrocyte processes of morphological and biological changes, enabling a dual mechanism of micrometer-scale mechanotransduction and phagocytic “tag-and-clear” for enhanced B cell depletion. CD20 EryPatches are designed to adhere to B cells and anchor on CD20 receptors across extensive cell surface areas. Their progressive discocyte-to-echinocyte transition provides deformability-driven traction, enabling localized, large-scale CD20 cross-linking that amplifies downstream apoptosis in target B cells. Concomitant biomarker alteration on CD20 EryPatch converts it into an “eat me” tag attached to the B cell, facilitating further clearance by initiating erythrophagocytosis. This approach proves more effective than standard CD20 monoclonal antibodies in models of B cell disorders, including non-Hodgkin lymphoma, systemic lupus erythematosus, and rheumatoid arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte DepletionB-LymphocytesErythrocytesPhagocytosisMechanotransduction, CellularAntigens, CD20ApoptosisAntibodies, MonoclonalHumansMaleAnimalsMiceCell LineMice, SCIDDisease Models, AnimalLymphoma, Non-HodgkinLupus Erythematosus, SystemicArthritis, RheumatoidMice, Inbred DBAFemale

Substanzen

Antigens, CD20Antibodies, Monoclonal

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…

ORCID-Profile: Jiaqi Liu, Fengju Wang, Lian Li

Förderung

  • National Natural Science Foundation of China
  • Department of Science and Technology of Sichuan Province
  • National key R&D program of China

Zitieren

APA

Liu, J., Wang, F., & Li, L. (2026). Erythrocyte patch for enhanced B cell depletion therapy. Science Advances, 12(21). https://doi.org/10.1126/sciadv.aed3138

Vancouver

Liu J, Wang F, Li L. Erythrocyte patch for enhanced B cell depletion therapy. Science Advances. 2026;12(21). doi:10.1126/sciadv.aed3138

BibTeX
@article{Liu2026,
  author = {Liu, Jiaqi and Wang, Fengju and Li, Lian},
  title = {Erythrocyte patch for enhanced B cell depletion therapy},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {21},
  doi = {10.1126/sciadv.aed3138}
}
Kostenlos starten →